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INTRODUCTION: Saphenous vein grafting is still widely used to revascularize ischemic myocardium. The effectiveness of this 
procedure is limited by neointima formation and accelerated atherosclerosis, which frequently leads to graft occlusion. A better 
understanding of this process is important to clarify the mechanisms of vein graft disease and to aid in the formulation of strategies 
for prevention and/or therapeutics. 
OBJECTIVE: To develop an ex vivo flow system that allows for controlled hemodynamics in order to mimic arterial and venous 
conditions. 
METHODS: Human saphenous veins were cultured either under venous (flow: 5 ml/min) or arterial hemodynamic conditions 
(flow: 50 ml/min, pressure: 80 mmHg) for 1-, 2- and 4-day periods. Cell viability, cell density and apoptosis were compared before 
and after these intervals using MTT, Hoeschst 33258 stain, and TUNEL assays, respectively. 
RESULTS: Fresh excised tissue segments were well preserved prior to the study. Hoechst 33258 and MTT stains showed progres-
sive losses in cell density and cell viability in veins cultured under arterial hemodynamic conditions from 1 to 4 days, while no 
alterations were observed in veins cultured under venous conditions. Although the cell density from 1-day cultured veins under 
arterial conditions was similar to that of freshly excised veins, the TUNEL assay indicated that most of these cells were undergo-
ing apoptosis. 
CONCLUSION: The results observed resemble the events taking place during early in vivo arterial-vein grafting and provide 
evidence that an ex vivo perfusion system may be useful for the identification of new therapeutic targets that ameliorate vein graft 
remodeling and increase graft patency over time.
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INTRODUCTION
Coronary artery bypass graft (CABG) is the standard 
procedure for the revascularization of ischemic heart tissue. 
Saphenous vein grafts were the first vascular conduits 
used in CABG, but their effectiveness has been limited 
by accelerated atherosclerosis that develops within the 
vein conduit.1,2 In contrast, arterial conduits display better 
long-term patency and have been increasingly used instead 
of venous grafts. Despite the increased usage of arterial 
conduits, full arterial revascularizations are carried out in 
only a small minority of eligible patients; currently, CABG 
surgery utilizes a combination of arterial and venous grafts.3,4 
However, a better understanding of the molecular events 
associated with the early arterialization of vein grafts may 
give rise to alternative approaches to overcoming the poor 
long-term patency of saphenous vein grafts.
In vivo, vein grafts are immediately subjected to 
increased hemodynamic stress, and the vein’s adaptive 
response may predispose later bypass occlusion. The 
morphological changes associated with the arterialization 
of veins have been well characterized, and several in vivo 
and in vitro studies have been performed to identify the 
molecular events taking place when stretch and shear 684
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stresses are increased.5-10 Ex vivo organ culture has also 
been used in vascular biology studies; most of the protocols 
make use of vessel rings that may be maintained up to 
8 days in culture media without tissue degeneration.11,12 
More recently, perfusion organ culture systems have been 
developed for the study of vessels under well-controlled 
hemodynamic conditions. Arteries kept in organ culture 
systems have been shown to be viable and with active 
vasomotion tone for up to 7 days.13,14 In contrast, vein 
culture studies have been limited to no more than 24 hours 
of culture.15,16 
In the present investigation, we developed an ex vivo 
perfusion system, which mimics in vivo hemodynamic 
conditions, allowing for the study of viable vein grafts 
under venous or arterial hemodynamic conditions for up to 
4 days. We demonstrated that this ex vivo system reproduces 
early events observed in in vivo animal models during the 
arterialization of vein grafts.
MATERIALS AND METHODS
Saphenous vein preparation
Saphenous veins were obtained from patients undergoing 
aortocoronary bypass surgery at the Heart Institute (InCor), 
University of São Paulo Medical School. The vein segments 
were kept in physiological solution until mounting in the 
culture system. This study protocol was approved by the 
local ethical committee (SDC – 1834/01/22, CAPPesq – 
299/01).
Organ culture system
The organ culture system is schematically represented in 
Figure 1. The vessel chamber was connected to a perfusion 
system where the media from the reservoir was pumped at a 
set flow rate. This circuit was adapted from the CELLMAX 
Artificial Capillary System (Spectrum Laboratories, Inc. 
Rancho Dominguez, CA) according to previously described 
methods.13 Vessel chambers and a pressure device were 
developed in-house to properly place the vessel segments and 
to enable pressure and flow to be controlled independently. 
The flow circuit was maintained in a humidified CO2 
incubator at 37°C.
Saphenous vein segments (approximately 2 cm each) 
were placed in the chamber filled with Dulbecco’s modified 
Eagle’s medium containing 10% fetal bovine serum, 100 U/
ml penicillin, and 100 µg/ml streptomycin. Vein segments 
from the same patient were connected to the perfusion 
system and cultured either under venous conditions (flow: 
5 ml/min) or arterial conditions (flow: 50 ml/min, pressure: 
80 mmHg) for 1, 2, or 4 days. Fresh, non-mounted segments 
were also collected for analysis.
All culture solutions were purchased from GIBCOTM 
(Invitrogen Corporation, Carlsbad, CA).
Histological analysis
Tissue samples were fixed in 4% phosphate-buffered 
formalin and embedded in paraplast (Oxford, St. Louis, 
MO). Sections of 3-µm thickness were stained with 
haematoxylin-eosin (HE) and Verhoeff’s-Van Gieson (VVG) 
for elastin. The sections were also used for Hoechst staining 
and TUNEL assays as described below.
Hoechst staining
Cell nuclei were labeled with Hoechst 33258 (Sigma 
Chemical Co., St. Louis, MO) as described previously.17 
Briefly, tissue sections were deparaffinized in citrisolv 
(Fisher Scientific Company, Pittsburgh, PA), rehydrated in 
serial alcohol dilutions, and treated with 0.5% Triton X-100 
for 15 min at 20 °C. The staining reaction was performed 
using Hoechst 33258 20 µg/ml diluted in assay buffer 
(mmol/L): NaCl 137, KCl 5, Na2HPO4 0.4, NaHCO3 4, 
glucose 5.5, MgCl2 2, EGTA 2, PIPES, pH 6.1. The sections 
were visualized under fluorescence microscopy (Carl Zeiss 
Inc., Thornwood, NY) and quantification was performed by 
an observer who was blinded to the hemodynamic conditions 
and duration of the cultures. Each section was measured at 
10 different randomly selected points and positive nuclei 
stains were quantified. Tissue area was quantified using 
Leica Qwin software (version 2.2) calibrated as per the 
manufacturer’s instructions (40X magnification, 1 pixel = 
0.228 µm). The cellular density was expressed as the total 
cell number per vessel area.
Figure 1 - Ex vivo perfusion system. Schematic representation of the system 
used for organ culture. It consists of a organ bath (A), a peristaltic pump 
station and a pressure apparatus controller (B) 685
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Terminal transferase-mediated dUTP nick end labeling 
(TUNEL) assay
DNA fragmentation was detected using the In Situ Cell 
Death Detection kit, AP (Roche Molecular Biochemicals, 
Mannheim, Germany) according to the manufacturer’s 
instructions. Briefly, tissue sections were deparaffinized 
in citrisolv, rehydrated in serial alcohol dilutions, and 
permeabilized with 0.5% Triton X-100 in 0.1% sodium 
citrate. The reaction with terminal deoxynucleotidyl 
transferase and alkaline phosphatase conversion was 
performed and the cross-sections were examined by light 
microscopy. Quantification was performed using Leica 
QWin software (version 2.2). TUNEL-positive cells and total 
cells were quantified by an observer who was blinded to the 
hemodynamic conditions and the duration of culture. The 
results were expressed as a percentage of TUNEL-positive 
cells among all cells evaluated. 
MTT stain
To verify tissue viability, the vein segments were stained 
with methylthiazol tetrazolium (MTT - Sigma Chemical Co., 
St. Louis, MO) as described elsewhere.14 When reduced by 
active mitochondria and other cellular enzymes, the MTT 
dye gives rise to a dark purple precipitate only in viable areas 
within the tissue fragments, making them readily visible. 
Briefly, the vein was incubated at 37°C for 1 hour with MTT 
0.5 mg/ml in PBS solution; then, pictures were taken from 
the samples submitted to both hemodynamic conditions.
Statistical Analyses
Data analyses were performed by two-way ANOVA, 
followed by Tukey’s post hoc test, as appropriate. Values for 
p < 0.05 were considered statistically significant.
RESULTS
The human saphenous vein segments were cultured 
under venous and arterial hemodynamic conditions for 1, 2 
and 4 days. Before and after these periods, analysis of cell 
viability, cell density, and apoptosis were performed. In 
the fresh excised segment of human saphenous vein, tissue 
morphology and integrity were verified by HE and VVG 
staining, and also by Hoechst 33258 nuclei stain and TUNEL 
assay (Figure 2). Furthermore, there was no evidence for 
apoptotic process indicating that the vessels used were well 
preserved (Figure 2).
The HE staining was also performed in vein segments 
cultured under venous and arterial conditions, and the 
number of nuclei stained by hematoxylin gradually 
diminished from 1 to 4 days when cultured in the arterial 
condition. No alteration was observed in veins cultured 
under venous conditions (data not shown). To further confirm 
the HE staining results, Hoechst 33258 nuclei staining was 
used to verify cell density in the vessel segments cultured 
under venous and arterial stimuli. As noted before, cellular 
density tended to decrease in specimens cultured under 
arterial conditions for 4 days, whereas no modification was 
observed in the veins cultured under venous conditions 
(Figures 3 and 4).
Tissue viability of the segments was examined by MTT 
staining (Figure 5). A control experiment was performed 
Figure 2 - Morphological and integrity analyses of fresh excised human 
saphenous vein. HE stain (A) and VVG stain (B) demonstrating the tissue 
structure. Hoechst 33258-labeled cell nuclei (C) and TUNEL assay (D) 
showing tissue cellular density with no presence of apoptotic processes. 
100X magnification
Figure 3 - Hoechst 33258 nuclei stain of human saphenous vein cultured in 
the ex vivo perfusion system. The segments were cultured under venous (A, 
C, E) and arterial (B, D, F) hemodynamic conditions for 1 (A, B), 2 (C, D) 
or 4 (E, F) days. 100X magnification686
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using a freshly isolated saphenous segment and a dead, 
refrigerated vessel. Since MTT stains only living cells, the 
fresh cross-section was completely stained, while no staining 
was observed in the dead vein segment (Figures 5A and 5B). 
The segments cultured under venous conditions from 1 to 4 
days contained viable cells throughout the vessel wall, but 
few viable cells were verified in segments cultured under 
arterial conditions for 4 days (Figure 5H). To examine if the 
decreased cell density and viability were due to apoptotic 
events, a TUNEL assay was performed to detect in situ DNA 
fragmentation (Figures 6 and 7). Almost no apoptotic cells 
were observed in the saphenous vein cultured under venous 
conditions for up to 4 days. In contrast, cultured segments 
maintained for 1 and 2 days under arterial hemodynamic 
stimuli showed portions with several TUNEL-positive cells 
(Figures 6B and 6D), suggesting that the cellular losses 
observed in the segments cultured for 4 days may have been 
a result of apoptosis. 
DISCUSSION
In this work, we present a perfusion organ culture system 
developed to mimic the arterialization of human saphenous 
vein grafts. This ex vivo culture system reproduces the initial 
events taking place when the grafted vein is submitted to 
arterial hemodynamic conditions and may be a valuable 
approach to the identification of molecular mechanisms 
underlying the early stages of bypass grafting, which have 
been validated in our lab using an in situ rat model (data not 
shown).
Figure 4 - Analysis of cellular density of human saphenous vein cultured in 
the ex vivo perfusion system. The results are expressed as mean ± standard 
error of total cell number per vessel area of 3-5 samples stained with Hoechst 
33258. () represents human saphenous vein cultured under venous condi-
tions and () under arterial conditions
Figure 5 - MTT stain of human saphenous vein cultured in the ex vivo 
perfusion system. The segments were cultured under venous (C, E, G) and 
arterial (D, F, H) hemodynamic conditions for 1 (C, D), 2 (E, F) or 4 (G, 
H) days. The freshly excised tissue (A) and dead samples (B) were used as 
positive and negative controls for the visualization of tissue viability. 1.5X 
magnification
Figure 6 - TUNEL assay of human saphenous vein cultured in the ex vivo 
perfusion system. The segments were cultured under venous (A, C, E) and 
arterial (B, D, F) hemodynamic conditions for 1 (A, B), 2 (C, D) or 4 (E, 
F) days. 100X magnification
Figure 7 - Analysis of apoptosis in human saphenous vein cultured in the ex 
vivo perfusion system. The results are expressed as mean ± standard error of 
percentage of TUNEL-positive cells of 3-5 samples. () represents human 
saphenous vein cultured under venous conditions and () under arterial 
conditions. * indicates p < 0.05 vs. venous condition687
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Several in vivo studies have demonstrated that cell 
apoptosis is induced during the initial period of arterial-vein 
graft due to increased tensile stress and strain.5,6,18,19 In our 
system, the cellular density and tissue viability decreased 
gradually in the human saphenous vein cultured under 
arterial conditions, whereas no changes in morphology or 
viability were observed when the veins were cultured up to 
4 days under venous hemodynamic conditions (Figures 3 
and 5). It is interesting to note that the cell density in veins 
cultured for 1 day under arterial conditions was similar to 
that in freshly excised samples, but a substantial number of 
these cells were TUNEL-positive, indicating the presence of 
apoptotic processes (Figures 3 and 6), which may explain the 
cellular losses observed in saphenous veins cultured under 
arterial hemodynamic conditions. It has been described that 
in vivo models of increased tensile stress induce cell death 
in vein grafts during the first 24 hours, and this process 
seems to be associated with increased caspase 3 activity.5,20 
More recently, Goldman et al.16 demonstrated that rat vena 
cava cultured under arterial conditions showed an increase 
in caspase 3 activity at 6 hours of culture and progressive 
-actin filament degradation and decreases in smooth muscle 
cell density over 48 hours, all of which are thought to be 
mediated by p38 MAPK.
It is generally accepted that vascular remodeling results 
from an imbalance between cell death and proliferation.6,20 In 
arterial-vein grafts, apoptosis occurs in response to increased 
mechanical stress, which is counterbalanced by subsequent 
proliferation processes. In rat vein graft models 10 to 30 days 
after surgery, it has been shown that early decreases in cellular 
density may be compensated for or may even increase in 
comparison to control veins.19 Liu et al.20 suggested that the 
initial cell death observed in experimental vein grafts possibly 
mediates the subsequent cellular proliferation. The absence 
of proliferation in saphenous veins cultured under arterial 
hemodynamic conditions in our system is not understood, but 
it may involve a lack of specific growth factors in the media 
culture used. Another possibility is that, under the present 
conditions, the proliferation process may require additional 
time beyond the 4-day observation period. However, it is 
important to emphasize that the lack of proliferation did not 
preclude the reproduction of other early events that have been 
observed in in vivo vein grafts, such as apoptotic processes 
and progressive decreases in cellular density and viability that 
may be associated with increased tensile stress.
The system presented here reproduced the early events 
observed in in vivo vein graft models with the advantage 
of working with human samples in very well controlled 
hemodynamic conditions. Although other components of 
blood circulation have an important role in vein graft failure, 
this ex vivo organ culture system provides the opportunity 
to study the effects of hemodynamic stimuli alone. We 
believe that the ex vivo organ culture is a useful model for 
characterizing the early molecular events taking place in 
the arterialization of human vein grafts and to provide new 
approaches to prolonging its lifespan. 
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